Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic Strategies

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) has a curative potential for many hematologic malignancies and blood diseases. However, the success of allo-HSCT is limited by graft-versus-host disease (GVHD), an immunological syndrome that involves inflammation and tissue damage media...

Descripción completa

Detalles Bibliográficos
Autores principales: Villa, Nancy Y., Rahman, Masmudur M., McFadden, Grant, Cogle, Christopher R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810275/
https://www.ncbi.nlm.nih.gov/pubmed/27011200
http://dx.doi.org/10.3390/v8030085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810275/
https://www.ncbi.nlm.nih.gov/pubmed/27011200
http://dx.doi.org/10.3390/v8030085

Ejemplares similares